[144] Idexx Laboratories Inc SEC Filing
IDEXX Laboratories Inc. filed a Form 144 to register the proposed sale of 5,450 shares of common stock, with an aggregate market value of $3,551,220.00, to be sold on NASDAQ through Morgan Stanley Smith Barney LLC. The filing lists 80,004,694 shares outstanding and shows an approximate sale date of 08/08/2025.
The shares were acquired via a stock option exercise on 08/08/2025 and paid in cash. The filer reports "Nothing to Report" for securities sold during the past three months and includes the standard attestation about material nonpublic information and trading-plan language. The provided content does not show a populated notice date or signature block.
- None.
- None.
Insights
TL;DR: Routine registration for an insider sale after an option exercise; size is very small relative to outstanding shares.
The Form 144 registers 5,450 common shares with an aggregate market value of $3,551,220, implying an approximate price of $651.13 per share based on the numbers disclosed. Relative to the 80,004,694 shares outstanding, the shares to be sold represent roughly 0.0068% of the outstanding float, indicating the transaction is unlikely to move the market. The sale is listed to be executed through Morgan Stanley Smith Barney LLC on NASDAQ, and the filer reports no sales in the prior three months.
TL;DR: Filing contains standard insider-sale attestation and trading-plan language; document lacks populated notice date/signature in provided content.
The form includes the customary representation that the selling party is unaware of undisclosed material adverse information and references Rule 10b5-1 trading-plan language as part of the attestation. The filing documents acquisition via a stock option exercise and payment in cash, and indicates no other sales in the past three months. The provided copy does not display a completed notice date or signature, which are administrative elements typically present on a final filing.
FAQ
What securities does IDEXX (IDXX) plan to sell according to this Form 144?
When is the approximate sale date listed on the Form 144 for IDXX?
Through which broker will the IDXX shares be sold?
How were the shares acquired according to the Form 144?
What is the aggregate market value and how many shares outstanding are reported?
Were there any securities sold by the filer in the past three months?
